What is the current Price Target for the Kazia Therapeutics Ltd Sponsored ADR stock?

The average Kazia Therapeutics Ltd Sponsored ADR target price is $3.00. This is 257.14% higher than the current stock price. 1 Analyst has issued a Kazia Therapeutics Ltd Sponsored ADR price target 2026.

How high will the Kazia Therapeutics Ltd Sponsored ADR stock rise?

No reliable answer can be given as to how high the Kazia Therapeutics Ltd Sponsored ADR stock will rise. The performance of stocks, including the Kazia Therapeutics Ltd Sponsored ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Kazia Therapeutics Ltd Sponsored ADR stock today?

The performance of Kazia Therapeutics Ltd Sponsored ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Kazia Therapeutics Ltd Sponsored ADR stock fall?

The decline in Kazia Therapeutics Ltd Sponsored ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Kazia Therapeutics Ltd Sponsored ADR Forecast, price target & analysts

$0.86

1.12% yesterday

Nasdaq, Feb 28, 09:10 pm CET

ISIN

US48669G1058

Symbol

KZIA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Kazia Therapeutics Ltd Sponsored ADR Target price 2025 - Analyst rating & recommendation

Kazia Therapeutics Ltd Sponsored ADR Classifications & Recommendation:

Buy

100%

Kazia Therapeutics Ltd Sponsored ADR Price Target

Target Price	$3.00
Price	$0.84
Potential	257.14% register free of charge
Number of Estimates	1

	1 Analyst has issued a Kazia Therapeutics Ltd Sponsored ADR price target 2026. The average Kazia Therapeutics Ltd Sponsored ADR target price is $3.00. This is 257.14% register free of charge higher than the current stock price.
	A rating was issued by 1 analysts: 1 Analysts recommend Kazia Therapeutics Ltd Sponsored ADR to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Kazia Therapeutics Ltd Sponsored ADR stock has an average upside potential 2026 of 257.14% register free of charge . Most analysts recommend the Kazia Therapeutics Ltd Sponsored ADR stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Jun '24	2025 Estimates
Earnings Per Share $	-6.66	-3.27
	10.84%	50.90%
P/E		negative

1 Analysts have issued a Kazia Therapeutics Ltd Sponsored ADR forecast for earnings per share. The average Kazia Therapeutics Ltd Sponsored ADR <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-6.66	10.84%
2025	$-3.27 50.90% Unlock
2026	$-1.60 51.07% Unlock
2027	$-1.24 22.50% Unlock
2028	$-1.14 8.06% Unlock
2029	$0.01 100.88% Unlock

Current	-0.13	64.86%
2025	-0.26 100.00% Unlock
2026	-0.53 103.85% Unlock
2027	-0.68 28.30% Unlock
2028	-0.74 8.82% Unlock
2029	66.74 9,118.92% Unlock

Kazia Therapeutics Ltd Sponsored ADR...

Current Kazia Therapeutics Ltd Sponsored ADR Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Maxim Group	Locked ➜ Locked	Locked	Feb 06 2025

Analyst Rating	Date
Locked Maxim Group: Locked ➜ Locked	Feb 06 2025

Discover more stocks with a high price target

Coinbase Global, Inc. 60.51%

BioNTech SE - ADR 30.07%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now